Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,019 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Identification of prognostic markers in transthyretin and AL cardiac amyloidosis.
Damy T, Jaccard A, Guellich A, Lavergne D, Galat A, Deux JF, Hittinger L, Dupuis J, Frenkel V, Rigaud C, Plante-Bordeneuve V, Bodez D, Mohty D. Damy T, et al. Among authors: dupuis j. Amyloid. 2016 Sep;23(3):194-202. doi: 10.1080/13506129.2016.1221815. Epub 2016 Sep 20. Amyloid. 2016. PMID: 27647161
Sequential cyclophosphamide-bortezomib-dexamethasone unmasks the harmful cardiac effect of dexamethasone in primary light-chain cardiac amyloidosis.
Le Bras F, Molinier-Frenkel V, Guellich A, Dupuis J, Belhadj K, Guendouz S, Ayad K, Colombat M, Benhaiem N, Tissot CM, Hulin A, Jaccard A, Damy T. Le Bras F, et al. Among authors: dupuis j. Eur J Cancer. 2017 May;76:183-187. doi: 10.1016/j.ejca.2017.02.004. Epub 2017 Mar 20. Eur J Cancer. 2017. PMID: 28334621
Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment.
Gounot R, Le Bras F, Dupuis J, Oghina S, Bodez D, Roulin L, Maarek A, Ladaique A, Beldi-Ferchiou A, Poullot E, Molinier-Frenkel V, Haioun C, Damy T, Belhadj K, Lemonnier F. Gounot R, et al. Among authors: dupuis j. Leuk Lymphoma. 2021 Apr;62(4):979-983. doi: 10.1080/10428194.2020.1850717. Epub 2020 Nov 29. Leuk Lymphoma. 2021. PMID: 33251891 No abstract available.
Venetoclax induces profound and sustained responses in patients with relapsed/refractory light-chain amyloidosis.
Pasquer H, Belhadj K, Dupuis J, Oghina S, Galat A, Ladaique A, Maarek A, Roulin L, Gounot R, Poulot E, Beldi-Ferchiou A, Molinier-Frenkel V, Haioun C, Damy T, Le Bras F, Lemonnier F. Pasquer H, et al. Among authors: dupuis j. Br J Haematol. 2021 May;193(3):674-677. doi: 10.1111/bjh.17380. Epub 2021 Mar 13. Br J Haematol. 2021. PMID: 33713427 No abstract available.
Evaluation of a new ELISA assay for monoclonal free-light chain detection in patients with cardiac amyloidosis.
Abroud H, Beldi-Ferchiou A, Audard V, Lemonnier F, Le Bras F, Belhadj K, Moktefi A, Poullot E, El Karoui K, Dupuis J, Maarek A, Roulin L, Delfau-Larue MH, Oghina S, Kharoubi M, Bézard M, Zaroui A, Damy T, Molinier-Frenkel V. Abroud H, et al. Among authors: dupuis j. EJHaem. 2022 Jun 24;3(3):828-837. doi: 10.1002/jha2.516. eCollection 2022 Aug. EJHaem. 2022. PMID: 36051065 Free PMC article.
Impact of [(18)F]fluorodeoxyglucose positron emission tomography response evaluation in patients with high-tumor burden follicular lymphoma treated with immunochemotherapy: a prospective study from the Groupe d'Etudes des Lymphomes de l'Adulte and GOELAMS.
Dupuis J, Berriolo-Riedinger A, Julian A, Brice P, Tychyj-Pinel C, Tilly H, Mounier N, Gallamini A, Feugier P, Soubeyran P, Colombat P, Laurent G, Berenger N, Casasnovas RO, Vera P, Paone G, Xerri L, Salles G, Haioun C, Meignan M. Dupuis J, et al. J Clin Oncol. 2012 Dec 10;30(35):4317-22. doi: 10.1200/JCO.2012.43.0934. Epub 2012 Oct 29. J Clin Oncol. 2012. PMID: 23109699 Clinical Trial.
Prognostic significance of Epstein-Barr virus in nodal peripheral T-cell lymphoma, unspecified: A Groupe d'Etude des Lymphomes de l'Adulte (GELA) study.
Dupuis J, Emile JF, Mounier N, Gisselbrecht C, Martin-Garcia N, Petrella T, Bouabdallah R, Berger F, Delmer A, Coiffier B, Reyes F, Gaulard P; Groupe d'Etude des Lymphomes de l'Adulte (GELA). Dupuis J, et al. Blood. 2006 Dec 15;108(13):4163-9. doi: 10.1182/blood-2006-04-017632. Epub 2006 Aug 10. Blood. 2006. PMID: 16902151 Free article. Clinical Trial.
Total metabolic tumor volume, circulating tumor cells, cell-free DNA: distinct prognostic value in follicular lymphoma.
Delfau-Larue MH, van der Gucht A, Dupuis J, Jais JP, Nel I, Beldi-Ferchiou A, Hamdane S, Benmaad I, Laboure G, Verret B, Haioun C, Copie-Bergman C, Berriolo-Riedinger A, Robert P, Casasnovas RO, Itti E. Delfau-Larue MH, et al. Among authors: dupuis j. Blood Adv. 2018 Apr 10;2(7):807-816. doi: 10.1182/bloodadvances.2017015164. Blood Adv. 2018. PMID: 29636326 Free PMC article.
Optimal oncologic management and mTOR inhibitor introduction are safe and improve survival in kidney and liver allograft recipients with de novo carcinoma.
Rousseau B, Guillemin A, Duvoux C, Neuzillet C, Tlemsani C, Compagnon P, Azoulay D, Salloum C, Laurent A, de la Taille A, Salomon L, Cholley I, Haioun C, Dupuis J, Wolkenstein P, Matignon MB, Grimbert P, Tournigand C. Rousseau B, et al. Among authors: dupuis j. Int J Cancer. 2019 Feb 15;144(4):886-896. doi: 10.1002/ijc.31769. Epub 2018 Nov 20. Int J Cancer. 2019. PMID: 30155929
Respective prognostic values of germinal center phenotype and early (18)fluorodeoxyglucose-positron emission tomography scanning in previously untreated patients with diffuse large B-cell lymphoma.
Dupuis J, Gaulard P, Hemery F, Itti E, Gisselbrecht C, Rahmouni A, Copie-Bergman C, Brière J, El Gnaoui T, Gaillard I, Meignan M, Haioun C. Dupuis J, et al. Haematologica. 2007 Jun;92(6):778-83. doi: 10.3324/haematol.10895. Haematologica. 2007. PMID: 17550850 Free article.
1,019 results